Literature DB >> 7720471

Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases.

A M Sawyerr1, M S Smith, A Hall, M Hudson, C R Hay, A J Wakefield, M G Brook, H Tomura, R E Pounder.   

Abstract

Serum concentrations of immunoreactive von Willebrand factor (vWF) and soluble thrombomodulin (TM), and vWF multimer patterns were measured to assess endothelial function in patients with inflammatory intestinal diseases. In Crohn's disease and acute infective diarrhea, vWF concentrations were significantly higher than in normal controls. In all patient groups, multimeric analysis of vWF and the concentration of serum TM were not different from normal controls. The results indicate alteration of endothelial function in inflammatory intestinal disorders. They may be compatible with the presence of localized vasculitis, but indicate that systemic endothelial destruction does not occur in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720471     DOI: 10.1007/bf02064981

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis.

Authors:  H E LOCKHART-MUMMERY; B C MORSON
Journal:  Gut       Date:  1960-06       Impact factor: 23.059

2.  Circulating von Willebrand factor in inflammatory bowel disease.

Authors:  T R Stevens; J P James; N J Simmonds; D A McCarthy; I F Laurenson; P J Maddison; D S Rampton
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Inducible secretion of large, biologically potent von Willebrand factor multimers.

Authors:  L A Sporn; V J Marder; D D Wagner
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

4.  Crohn's disease activity: assessment by factor VIII coagulation proteins.

Authors:  S Zielen; S W Bender; W Kreuz; H G Posselt; E Solem; I Scharrer
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-10       Impact factor: 2.839

5.  Factor VIII related antigen in the assessment of vasculitis.

Authors:  A D Woolf; G Wakerley; T B Wallington; D G Scott; P A Dieppe
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

6.  Arterial inflammatory-cell infiltration in Crohn's disease.

Authors:  S A Geller; A Cohen
Journal:  Arch Pathol Lab Med       Date:  1983-09       Impact factor: 5.534

7.  Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells.

Authors:  H Ishii; H Uchiyama; M Kazama
Journal:  Thromb Haemost       Date:  1991-05-06       Impact factor: 5.249

8.  Fibrin induces release of von Willebrand factor from endothelial cells.

Authors:  J A Ribes; C W Francis; D D Wagner
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

9.  IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.

Authors:  G B Zavoico; B M Ewenstein; A I Schafer; J S Pober
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  3 in total

1.  Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation.

Authors:  Petros Zezos; Georgia Papaioannou; Nikolaos Nikolaidis; Themistoclis Vasiliadis; Olga Giouleme; Nikolaos Evgenidis
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 2.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

Review 3.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.